X4 Pharmaceuticals, Inc. (XFOR) Social Stream



X4 Pharmaceuticals, Inc. (XFOR): $1.04

0.01 (-0.95%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add XFOR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#221 of 359

in industry

X4 PHARMACEUTICALS INC (XFOR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XFOR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 6 $27 $15 $19.333 $1.2 1511.08%
2021-12-14 7 $27 $11 $17.666 $1.2 1372.17%
2021-12-16 7 $27 $10 $16.833 $1.2 1302.75%
2021-12-19 7 $28 $10 $17 $1.2 1316.67%
2022-01-03 7 $28 $10 $17.333 $1.2 1344.42%
2022-03-18 7 $28 $10 $16.166 $1.2 1247.17%
2022-03-21 7 $28 $10 $14.166 $1.2 1080.5%
2022-05-12 7 $28 $10 $13.571 $1.2 1030.92%
2022-05-13 7 $28 $8 $12.357 $1.2 929.75%
2022-05-19 7 $28 $7 $11.928 $1.2 894%
2022-08-04 6 $10 $5 $7.5 $1.2 525%
2022-08-05 6 $10 $3.5 $6.666 $1.2 455.5%
2022-11-03 6 $10 $3.5 $6.166 $1.2 413.83%
2022-11-29 6 $10 $3.5 $6.333 $1.2 427.75%
2022-11-30 5 $10 $5 $6.583 $1.2 448.58%
2022-12-08 6 $10 $4.5 $6.25 $1.2 420.83%
2022-12-12 7 $10 $3 $5.785 $1.2 382.08%
2022-12-22 8 $10 $3 $5.437 $1.2 353.08%
2023-03-22 8 $10 $3 $4.937 $1.2 311.42%
2023-03-24 8 $7 $3 $4.071 $1.2 239.25%
2023-05-08 8 $4.5 $3 $3.5 $1.2 191.67%
2023-05-21 8 $5 $2.6 $3.514 $1.2 192.83%
2023-05-22 8 $5 $2.6 $3.657 $1.2 204.75%
2023-08-11 8 $5 $2.6 $3.762 $1.2 213.5%
2023-08-15 8 $5 $2.6 $3.637 $1.2 203.08%
2023-08-30 8 $5 $2.6 $3.512 $1.2 192.67%

The Trend in the Analyst Price Target


XFOR's average price target has moved down $2.27 over the prior 37 weeks.

Over the past 48 weeks, XFOR's average upside potential has been 292.83%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-09-28 6 10.0 3.5 6.166 1.450 325.24%
2022-12-22 8 10.0 3.0 5.437 0.843 544.96%
2023-05-08 8 4.5 3.0 3.500 1.630 114.72%
2023-05-21 8 5.0 2.6 3.514 2.100 67.33%
2023-08-15 8 5.0 2.6 3.637 1.200 203.08%

XFOR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 8 0 0 0 0 8

The Trend in the Broker Recommendations


Over the past 19 months, XFOR's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XFOR as an investment opportunity.

  • X4 PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 3242.43% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, X4 PHARMACEUTICALS INC's average analyst price target is higher than 352.66% of them.
  • In the context of all US stocks, X4 PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2839.41% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, X4 PHARMACEUTICALS INC's number of analysts covering the stock is higher than 2877.86% of them.

Stocks similar to X4 PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APTO, CLLS, and ADAP.

Is XFOR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!